Retraction

Increased Aβ2-α7-like nicotinic acetylcholine receptor complex level in lymphocytes is associated with apolipoprotein E4-driven Alzheimer's disease pathogenesis

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1186/s13195-022-01024-5
Additional Notes:

see also: https://pubpeer.com/publications/B8A32AD7E71A128B6897D4315AC065

Citations (14)

14
Total Citations
3
Post-Retraction
(21.4%)
11
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
1 After 2+ years
758 Days since retraction (latest)
Specific interaction from different Aβ42 peptide fragments to α7nAChR-A study of molecular dynamics simulation
Xvzhi Gao, Yvning Guan, Chuanbo Wang et al. (7 authors)
Journal of Molecular Modeling
Published: Jun 2024
758 days after retraction
Navigating the dementia landscape: Biomarkers and emerging therapies
Shubhrat Maheshwari, Aditya Singh, Valeed Ahmad Ansari et al. (7 authors)
Ageing Research Reviews
Published: Jan 2024
17 citations
588 days after retraction
Physiological Roles of β-amyloid in Regulating Synaptic Function: Implications for AD Pathophysiology
Wenwen Cai, Linxi Li, Shaoming Sang et al. (5 authors)
Neuroscience Bulletin Open Access
Published: Nov 2022
48 citations
180 days after retraction
Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer’s Disease
Awesh K. Yadav, Farhan Mazahir
CNS & Neurological Disorders - Drug Targets
Published: Apr 2022
4 citations
40 days before retraction
α7 nicotinic acetylcholine receptors in the hippocampal circuit: taming complexity
Ayland C. Letsinger, Zhenglin Gu, Jerrel L. Yakel
Trends in Neurosciences Open Access
Published: Dec 2021
46 citations
170 days before retraction
Preventing dementia? Interventional approaches in mild cognitive impairment
Vanessa J. Lissek, Boris Suchan
Neuroscience & Biobehavioral Reviews
Published: Jan 2021
89 citations
506 days before retraction
[Establishment of a gp120 transgenic mouse model with α7 nAChR knockout].
Tongtong Hu, Zelong Gong, Yu Wan et al. (8 authors)
PubMed
Published: Aug 2020
1 citation
640 days before retraction
Synaptosome as a tool in Alzheimer’s disease research
Faraz Ahmad, Ping Liu
Brain Research
Published: Jul 2020
29 citations
691 days before retraction
PTI-125 REDUCES BIOMARKERS OF ALZHEIMER’S DISEASE IN PATIENTS
H.-Y. Wang, Zhen‐Ming Pei, K.-C. Lee et al. (10 authors)
The Journal of Prevention of Alzheimer s Disease
Published: Jan 2020
35 citations
882 days before retraction
Aβ42-α7-like nicotinic acetylcholine receptors and Alzheimer’s disease
Hoau-Yan Wang, Amber Khan
Elsevier eBooks
Published: Jan 2020
2 citations
882 days before retraction
Insulin and adipokine signaling and their cross-regulation in postmortem human brain
Hoau-Yan Wang, Ana W. Capuano, Amber Khan et al. (9 authors)
Neurobiology of Aging Open Access
Published: Aug 2019
7 citations
1016 days before retraction
Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease
Darshpreet Kaur, Vivek Sharma, Rahul Deshmukh
Inflammopharmacology
Published: Mar 2019
389 citations
1175 days before retraction
ApoE-fragment/Aβ heteromers in the brain of patients with Alzheimer’s disease
Amandine Mouchard, Marie-Charlotte Boutonnet, Claire Mazzocco et al. (5 authors)
Scientific Reports Open Access
Published: Mar 2019
30 citations
1181 days before retraction
Postnatal chlorpyrifos exposure and apolipoprotein E (APOE) genotype differentially affect cholinergic expression and developmental parameters in transgenic mice
Pia Basaure, Laia Guardia-Escote, María Cabré et al. (7 authors)
Food and Chemical Toxicology
Published: May 2018
23 citations
1490 days before retraction
Quick Stats
Total Citations: 14
Years Since Retraction: 3.5 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers